Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder.

Saghafi R, Brown C, Butters MA, Cyranowski J, Dew MA, Frank E, Gildengers A, Karp JF, Lenze EJ, Lotrich F, Martire L, Mazumdar S, Miller MD, Mulsant BH, Weber E, Whyte E, Morse J, Stack J, Houck PR, Bensasi S, Reynolds CF 3rd.

Int J Geriatr Psychiatry. 2007 Nov;22(11):1141-6.

PMID:
17486678
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial.

Lavretsky H, Alstein LL, Olmstead RE, Ercoli LM, Riparetti-Brown M, Cyr NS, Irwin MR.

Am J Geriatr Psychiatry. 2011 Oct;19(10):839-50. doi: 10.1097/JGP.0b013e31820ee9ef.

PMID:
21358389
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.

Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan PT, Kane CP.

CNS Drugs. 2011 Mar;25(3):227-38. doi: 10.2165/11586460-000000000-00000.

PMID:
21323394
[PubMed - indexed for MEDLINE]
4.

International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.

Williams LM, Rush AJ, Koslow SH, Wisniewski SR, Cooper NJ, Nemeroff CB, Schatzberg AF, Gordon E.

Trials. 2011 Jan 5;12:4. doi: 10.1186/1745-6215-12-4.

PMID:
21208417
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
[PubMed - indexed for MEDLINE]
6.

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.

Curr Med Res Opin. 2006 Jul;22(7):1331-41.

PMID:
16834832
[PubMed - indexed for MEDLINE]
7.

Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram.

Papakostas GI, Larsen K.

Eur Arch Psychiatry Clin Neurosci. 2011 Apr;261(3):147-56. doi: 10.1007/s00406-010-0149-3. Epub 2010 Sep 22.

PMID:
20859636
[PubMed - indexed for MEDLINE]
8.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
[PubMed - indexed for MEDLINE]
9.

Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.

Brown ES, Howard C, Khan DA, Carmody TJ.

Psychosomatics. 2012 Jan-Feb;53(1):75-80. doi: 10.1016/j.psym.2011.07.009.

PMID:
22221724
[PubMed - indexed for MEDLINE]
10.

Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.

Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.

Clin Ther. 2007 Nov;29(11):2319-32.

PMID:
18158074
[PubMed - indexed for MEDLINE]
11.

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.

Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S.

Psychiatry Res. 2009 Sep 30;169(2):132-8. doi: 10.1016/j.psychres.2009.04.004. Epub 2009 Aug 26.

PMID:
19709754
[PubMed - indexed for MEDLINE]
12.

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

Bobo WV, Chen H, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Lesser IM, Kornstein SG, Wisniewski SR, Rush AJ, Shelton RC.

J Affect Disord. 2011 Oct;133(3):467-76. doi: 10.1016/j.jad.2011.04.032. Epub 2011 May 23.

PMID:
21601287
[PubMed - indexed for MEDLINE]
13.

Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.

Sung SC, Wisniewski SR, Balasubramani GK, Zisook S, Kurian B, Warden D, Trivedi MH, Rush AJ; CO-MED Study Team.

Psychol Med. 2013 May;43(5):945-60. doi: 10.1017/S0033291712001742. Epub 2012 Dec 11.

PMID:
23228340
[PubMed - indexed for MEDLINE]
14.

Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.

Demyttenaere K, Andersen HF, Reines EH.

Int Clin Psychopharmacol. 2008 Sep;23(5):276-86. doi: 10.1097/YIC.0b013e328303ac5f.

PMID:
18703937
[PubMed - indexed for MEDLINE]
15.

Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.

Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M, Davis LL, Balasubramani GK, McGrath PJ, Berman SR.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):248-60. doi: 10.1016/j.drugalcdep.2008.08.010. Epub 2008 Nov 5.

PMID:
18986774
[PubMed - indexed for MEDLINE]
16.
17.

Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.

Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N.

Pharmacoeconomics. 2008;26(11):969-81.

PMID:
18850765
[PubMed - indexed for MEDLINE]
18.

Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.

Mohamed S, Osatuke K, Aslam M, Kasckow J.

Am J Geriatr Pharmacother. 2006 Sep;4(3):201-9.

PMID:
17062320
[PubMed - indexed for MEDLINE]
19.

Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: a 12-week, open-label prospective trial.

Park HY, Lee BJ, Kim JH, Bae JN, Hahm BJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):318-23. doi: 10.1016/j.pnpbp.2011.11.010. Epub 2011 Nov 28.

PMID:
22142651
[PubMed - indexed for MEDLINE]
20.

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.

Lepola U, Wade A, Andersen HF.

Int Clin Psychopharmacol. 2004 May;19(3):149-55. Erratum in: Int Clin Psychopharmacol. 2004 Jul;19(4):255.

PMID:
15107657
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk